<< Read Full Article
CHANGE IN RATINGS
Amgen (AMGN Quote) upgraded at Bernstein from Market Perform to Outperform. Company should benefit from a re-acceleration of sales and earnings growth next year.ARRIS Group (ARRS Quote) downgraded at Needham to Hold from Buy. Cites indications of lessening demand for 3.0 CPE gear for 2010 and full valuation in the stock price.
Boston Scientific (BSX Quote) rated new Hold at Collins Stewart. $9 price target. Management is executing well, but faces slower future sales growth.
Frontier Oil (FTO Quote) downgraded at Credit Suisse to Neutral from outperform based on downside risks to earnings. Decreased target price to $14 from $16. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,301.23 | 1,098.38 | 2,198.21 | 35.06 |
Oil *
73.68
|
|
DOWN
7.03
|
UP
2.31
|
UP
18.16
|
UP
0.19
|
10 Yr
3.51%
SPDR Gold
108.98
|
|
-0.07%
|
+0.21%
|
+0.83%
|
+0.54%
|
Data delayed 20 minutes |
Connect with TheStreet